Colin Exline

Company: Primera Therapeutics

Job title: Head of Gene Editing

Seminars:

Panel Discussion: Addressing Safety of Delivery via Viral or Non-Viral Modes in Response to Concerns in the Ex Vivo Space 12:00 pm

Navigating the safety of delivery mechanisms to collaborate in ensuring vectors are as safe as possible Clarifying the latest FDA guidelines in the ex vivo CAR-T space to apply insights to the in vivo space Evaluating how this may impact in vivo pipelines using viral vectors to plan for the futureRead more

day: Conference Day Two

Panel Discussion: Improving Target Specificity by Reviewing Methods to Reduce Off-Site Effects & Innovations Needed to Increase Target Precision 11:30 am

Identifying challenges in target specificity to collaboratively review current techniques Assessing the advantages and disadvantages of each method to improve target specificity Planning for future improvements and driving new innovations to elevate target specificityRead more

day: Conference Day One